Trial Profile
A study investigating long-term vision and anatomic effects of Ranibizumab with prompt or deferred laser versus laser or triamcinolone plus deferred Ranibizumab in patients with diabetic macular edema
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Oct 2016
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary) ; Triamcinolone
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 17 Oct 2016 New trial record